Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +4.1%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (617)

clinicaltrialsPublishedShowing 51–70 of 70 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01677949	Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia	withdrawn	Phase 2	0	Masonic Cancer Center, University of MinnesotaOTHER	1	Dec 2, 2017	clinicaltrials
NCT00101140	Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission	withdrawn	Phase 2	0	Eastern Cooperative Oncology GroupNETWORK	0	Oct 19, 2017	clinicaltrials